1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow QL1203 + mFOLFOX6: new trials by email Literature Review of QL1203 + mFOLFOX6 trials Research Report on QL1203 + mFOLFOX6
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment of RAS Wild-type Metastatic Colorectal Cancer QL1203 + mFOLFOX6, Vectibix®+ mFOLFOX6 - RAS Wild-type Metastatic Colorectal Cancer | Phase 1 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 136 | 2026-11-24 | 2026-09-21 |